| Filed On | Filing |
|---|---|
| 17 May 2022 |
Form 4/A: Laukien Frank H, Director
Bought 1,710 shares ($98.6K) |
| 16 Sep 2019 |
Form 4/A: Prause Burkhard, Pres. & CEO, Bruker EST
Received 15,702 shares by exercise or conversion ($319K) |
| 16 Aug 2017 |
Form 4/A: Munch Mark, Exec VP&Pres Bruker Nano Inc.
Gave up 2,120 shares to cover exercise price or tax ($58K) |
| 16 Aug 2017 |
Form 4/A: Mattacchione Anthony L, Senior Vice President & CFO
Received 22,858 shares as a grant or award |
| 12 May 2016 |
Form 4/A: Emmerich Wolf-Dieter, Director
Acquired 0 shares (Other Transaction) · Granted 3,000 Stock option (right to buy) |
| 10 Mar 2016 |
Form 4/A: Laukien Joerg C, Director
Received 5,200 shares by exercise or conversion ($64.4K) |
| 09 Mar 2016 |
Form 4/A: Laukien Joerg C, Director
Received 5,200 shares by exercise or conversion ($64.4K) |
| 03 Sep 2014 |
Form 4/A: Bachmann Thomas Werner, President Bruker BioSpin Group
Received 13,700 shares as a grant or award · Granted 11,227 Stock Option (Right to Buy) |
| 15 May 2012 |
Form 4/A: Laukien Frank H, Director
Received 25,000 shares by exercise or conversion ($330K) |
| 05 Apr 2012 |
Form 4/A: Laukien Frank H, Director
Received 75,000 shares by exercise or conversion ($656K) |
| 24 Mar 2011 |
Form 4/A: Wangler Bernhard, Director
Received 2,500 shares by exercise or conversion ($35K) |
| 08 Aug 2007 |
Form 4/A: Laukien Frank H, Director
Granted 100,000 Stock option (right to buy) |
| 04 Apr 2007 |
Form 4/A: Laukien Joerg C, Director
Holds 0 Stock Option (Right to Buy) |
Loading...